Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer

por Chavan, Sushant V., Maitra, Anurupa, Roy, Nobhojit, Chavan, Padma R.
Publicado 2014

A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

por Chavan, Sushant V., Chavan, Niraj R., Balaji, Anusha, Trivedi, Vatsala D., Chavan, Padma R.
Publicado 2011